Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer

Overview of attention for article published in Clinical Pharmacokinetics, August 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,508 followers.

Zepsyre . Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer. https://t.co/iyhYuKjHeY https://t.co/TaAAYte7pa

09 Aug 2018

Reply Repost Favourite